An interventional study of GoCheck Kids (iOS) and GoCheck Kids (Windows) in Amblyopia, sponsored by Gobiquity Mobile Health. Completed. Open to participants aged 1 Year to 6 Years. Per ClinicalTrials.gov, last updated 2018-03-13.
Sponsored by Gobiquity Mobile Health · Not applicable, Interventional, and Screening
Objective: Prospective evaluation of GoCheckKids™, a smartphone application ('App') as a photo screening device in a pediatric population to detect amblyopia risk factors (ARFs)
Method: Photorefraction images are captured using up to 4 different devices with GoCheckKids™ App and patients are evaluated with cycloplegic refraction.
189 studies on the registry are indexed under Amblyopia; 41 are open to participants now.
This study's enrollment of 358 is above the median of 60 across 137 interventional studies indexed under Amblyopia.
Browse Amblyopia studies →Gobiquity Mobile Health is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinical Validation of GoCheck Kids Smartphone App
Device: GoCheck Kids (iOS) · Device: GoCheck Kids (Windows)
Photorefraction method is used to screen amblyopia risk factors.
Photorefraction method is used to screen amblyopia risk factors.
Sensitivity and specificity of amblyopia risk factors detected by photo refraction
Identification of risk factors as compared to gold standard cycloplegic refraction
Time frame: 1 Day
Number of patients with gaze error identified by photo screening
Detection of gaze error compared to cover test examination results
Time frame: 1 day
No study locations are listed for this record.
Ran from Nov 2016 to primary completion in Mar 2017, 4 months.
Of 71 interventional studies with no phase under Amblyopia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 47. This study's 4 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.